"Navigating the Modern News Zoo so you don't have to."
Sunday, July 13, 2025
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.
Get Ready For The Market Melt-Up
- Preliminary Report Into Last Month’s Air India Crash Provides New Information - Timothy Sekerak
- Channel 5’s Murder Most Puzzling Is the Ultimate Guessing Game for Cosy Crime Lovers - Liam Dearden
- How To Sell Replicas Legally In 2025? 8 Steps Guide - Robina Anwar
- The countdown’s almost over: 2 days until TechCrunch All Stage 2025 kicks off in Boston - TechCrunch Events
- New research reveals how male and female brains process regret and change decisions
- The Most Banned Sci-Fi Movies - Drew Dietsch
Chaos at Spirit Airlines ticket counter over cancelled flight
- About That Farm Raid the Democrats Are So Angry About...
- Why The Prisoner Failed - Joshua Tyler
- Best Prime Day deals on Amazon devices: It's the last day to get up to 68 percent off Kindle ereaders, Echo speakers and more - Valentina Palladino
- Keir Starmer humiliated on BBC show as David Tennant’s brutal dig leaves panel speechlesss - Isaiah Amos
- The 7 Most Unfairly Overlooked Sci-Fi Movies Of The 2000s - Joshua Tyler
- Slots player hits $1.1 million jackpot at Las Vegas Strip resort
